ubidecarenone (Q21656): Difference between revisions
Jump to navigation
Jump to search
Created claim: medical condition treated (P663): chronic fatigue syndrome (Q12840) |
Created claim: has part(s) (P8): carbon (Q3196) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Property / subject has role | |||
| Property / subject has role: vitamin / rank | |||
Normal rank | |||
| Property / subject has role | |||
| Property / subject has role: primary metabolite / rank | |||
Normal rank | |||
| Property / has part(s) | |||
| Property / has part(s): oxygen / rank | |||
Normal rank | |||
| Property / has part(s) | |||
| Property / has part(s): carbon / rank | |||
Normal rank | |||
Latest revision as of 21:12, 2 April 2024
chemical compound
- Ubiquinone
- Coenzyme Q-10
- all-trans-ubiquinone
- CoQ10
- Q
- Q10
- CoQ
- Coenzyme Q10
- Kudesan
- Ubiquinone Q10
- Li-Q-Sorb
- Kaneka Q10
- 2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-Benzoquinone
- (all-E)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-Cyclohexadiene-1,4-dione
- Neuquinone
- Q-Gel
- Q-Gel 100
- Ensorb
- Aqua Q10
- PureSorb Q 40
- Unbiquinone
- Neuquinon
- Aqua Q 10L10
- 4-Ethyl-5-fluoropyrimidine
- Liquid-Q
- (all-E)-2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-Cyclohexadiene-1,4-dione
- Unispheres Q 10
- 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-Cyclohexadiene-1,4-dione
- Q 10AA
- Bio-Quinon
- Ubiquinone-10
- Bio-Quinone Q10
- Ubidecarenone
- ubiquinone
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ubidecarenone |
chemical compound |
|
Statements
C₅₉H₉₀O₄
0 references